Enzo Biochem, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 78   

Articles published

ENZ 4.36 -0.02 (-0.46%)
price chart
Enzo Biochem, Inc. Pipeline Review, Market Growth, Segment, Trends and ...
MRS54 “Enzo Biochem, Inc.Pipeline Review, H2 2015“, provides an overview of the Enzo Biochem, Inc.
Acadian Asset Management Buys 513009 Shares of Enzo Biochem, Inc. (ENZ)
Enzo Biochem logo Acadian Asset Management increased its stake in Enzo Biochem, Inc. (NYSE:ENZ) by 1,092.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission.
Enzo Biochem, Inc. (ENZ) Lifted to "Hold" at Zacks Investment Research
Zacks Investment Research upgraded shares of Enzo Biochem, Inc. (NYSE:ENZ) from a sell rating to a hold rating in a research report sent to investors on Wednesday, MarketBeat.
Lone Star Value Issues Open Letter to Shareholders of Enzo Biochem, Inc.
Lone Star Value Management, LLC ("Lone Star Value") is an investment firm that invests in undervalued securities and engages with its portfolio companies in a constructive way to help maximize value for all shareholders.
Form 8-K ENZO BIOCHEM INC For: Dec 21  StreetInsider.com
Enzo Biochem Issues Open Letter to Shareholders  Business Wire (press release)
Enzo Biochem, Inc. (ENZ) Upgraded to Hold at Zacks Investment Research
Enzo Biochem, Inc. logo Zacks Investment Research upgraded shares of Enzo Biochem, Inc. (NYSE:ENZ) from a sell rating to a hold rating in a report published on Saturday, MarketBeat reports.
Enzo Biochem, Inc. (ENZ) Raised to "Hold" at Zacks Investment Research
Enzo Biochem logo Enzo Biochem, Inc. (NYSE:ENZ) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday, Analyst Ratings.
Enzo Biochem, Inc. (ENZ) Upgraded to "Hold" at Zacks Investment Research
Enzo Biochem, Inc. logo Zacks Investment Research upgraded shares of Enzo Biochem, Inc. (NYSE:ENZ) from a sell rating to a hold rating in a research report sent to investors on Wednesday, AnalystRatings.
Enzo Biochem, Inc. (NYSE:ENZ) Short Interest Update  The Daily Rover
News Activity: Enzo Biochem Inc. (NYSE:ENZ), Commerce Bancshares (NASDAQ ...  Property Mentor
Zacks: Enzo Biochem, Inc. (NYSE:ENZ) Given $6.00 Average Target Price by Analysts
Enzo Biochem logo Enzo Biochem, Inc. (NYSE:ENZ) has been given an average broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the stock, Zacks Investment Research reports.
Enzo Biochem Updates Corporate Developments at Annual Shareholders Meeting
NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) announced the results of its Annual Shareholders Meeting today and updated shareholders on its businesses.
Enzo Biochem, Inc. (ENZ) Upgraded by Zacks Investment Research to "Hold ...  Zolmax
Enzo Biochem (ENZ) Reaches Patent Infringement Settlement with Agilent (A)  StreetInsider.com
Enzo Biochem, Inc. (ENZ) Stock Rating Upgraded by Zacks Investment Research
Enzo Biochem logo Enzo Biochem, Inc. (NYSE:ENZ) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Wednesday, Marketbeat.